Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.21.1
Condensed Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue:    
Total revenue $ 1,407,165 $ 270,787
Revenue from Contract with Customer, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember
Costs and expenses:    
Research and development $ 2,431,860 $ 283,114
Selling, general and administrative 1,600,576 527,688
Total costs and expenses 4,032,436 810,802
Loss from operations (2,625,271) (540,015)
Interest expense (11,797) (7,425)
Net loss $ (2,637,068) $ (547,440)
Net loss per share – basic and diluted $ (0.26) $ (0.07)
Weighted-average number of common shares – basic and diluted 10,053,949 8,181,734